Inviting all the participants over the globe to the 2nd International Conference on Respiratory Disease and Care going to be held during August 16-17, 2021 at Berlin, Germany. Respiratory Care 2021 is based on the theme "Current Challenges and Innovations Therapeutics in Respiratory care".
Respiratory Care 2021 welcomes Pulmonologists, Respirologists, Respiratory Care Practitioners (RCP), and Respiratory Medicine specialists across the globe to discuss current trends in respiratory disease screening to diagnosis, treatment, and management. Strategic sessions of Pulmonary & Respiratory Medicine covering about almost all of the Respiratory Diseases such as COPD, Asthma, Allergy, cystic fibrosis, pneumonia, tuberculosis, emphysema, Lung Cancers, complicated chest infections, pulmonary fibrosis, Sleep Apnea, Interstitial lung disease, Lung nodules, chronic cough, Influenza, mycobacterial infection, Pediatric Pulmonary, Bronchiectasis, Critical Care, etc. and also health care discipline specializing in the promotion of optimum cardiopulmonary function, health, and wellness.
This Pulmonology & Respiratory care Congress composed of well-organized scientific sessions, plenary sessions, Oral presentations, Poster presentations, one-to-one meetings, networking sessions, e-poster presentations, Young Researcher Forums (YRFs), B2B meetings, International workshops, Symposiums, Industrial sessions, Exhibitor presentations, etc.
Session 1: COVID-19 and Respiratory System
When the coronavirus receives into the frame, it comes into touch with the mucous membranes that line the nose, mouth, and eyes. The virus enters a healthful cell and uses the cell to form new virus parts. It multiplies, and therefore the fresh viruses infect nearby cells. Think tract as an upside-down tree. The trunk may be a trachea or windpipe. It splits into smaller and smaller branches within the lungs. At the top of each department are tiny air sacs referred to as alveoli. this is often where oxygen goes into the blood and CO2 comes out.
The coronavirus disorder (COVID-19) pandemic is horrifying for all citizenry, except for those with asthma, there's the terrific worry that they will have a worse outcome or be far more likely to urge SARS-CoV-2. It's vital to understand that currently there is no proof of increased infection prices in those with asthma. And albeit the Centers for Disease Control and Prevention states those patients with moderate-severe asthma are often at a greater hazard for the more excessive disorder, there are not any published facts to assist this willpower at this point.
Session 3: Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease, commonly mentioned as COPD, maybe a group of progressive lung diseases. The most common are emphysema and chronic bronchitis. Many people with COPD have both of those conditions. COPD makes it harder to breathe. There’s no single test for COPD. Diagnosis is based on symptoms, a physical exam, and diagnostic test results. Treatment can ease symptoms, prevent complications, and generally slow disease progression. Your healthcare team may include a lung specialist (pulmonologist) and physical and respiratory therapists.
Session 4. Lung Cancer
The level of lung cancers mostly refers to the extent to which the cancer has unfolded within the body. Treatment of lung cancers can involve a mixture of surgery, chemotherapy, centered remedy, immunotherapy, and radiation remedy in addition to more modern experimental methods. The well-known diagnosis of lung most cancers is bad because medical doctors tend not to discover the disease till it is at an advanced stage. Five-year survival is around 54% for early level lung cancer sufferers that have a tumor localized to the lungs, but handiest around 4% in those with advanced, inoperable lung cancer. Smoking cessation is the most crucial measure that can save you the improvement of lung cancer.
Session 5: Pneumonia
Pneumonia is typically precipitated by using contamination with viruses or bacteria and less normally via other microorganisms, certain medicinal drugs and conditions which include autoimmune diseases. Risk elements consist of cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, diabetes, heart failure, records of smoking, a poor potential to cough such as following a stroke, and a susceptible immune system. Diagnosis is often based on the signs and symptoms and bodily examination. Chest X-ray, blood tests, and lifestyle of the sputum may also help affirm the diagnosis. The disease may be classified via in which it was acquired with community, hospital, or health care related pneumonia.
Session 6: Cardio Pulmonary Disorders
The two primary tobacco-associated cardiopulmonary illnesses are Cardiovascular Disease (CVD) and Chronic Obstructive Pulmonary Disorder (COPD). Exposure to tobacco smoke has long been diagnosed as a prominent chance component for Cardiovascular Disease. Similarly minimizing exposure to tobacco smoke is the most effective manner to save you COPD. However, the mechanisms by way of which tobacco toxicants increase the danger of Cardiovascular Disease and result in the onset of COPD are nonetheless unclear. Despite discounts in smoking during the last decade, Cardiovascular Disease and COPD stay the first and second main causes of death among smokers. It is important to keep in mind also that for all of us who dies because of smoking; as a minimum 30 people live with a critical smoking-associated illness.
Session 7: Idiopathic Pulmonary Fibrosis
The purpose of Idiopathic pulmonary fibrosis is unknown however sure environmental elements and exposures have been proven to growth the risk of getting Idiopathic pulmonary fibrosis. Cigarette smoking is the first-rate diagnosed and maximum accepted risk issue for Idiopathic pulmonary fibrosis, and increases the danger of Idiopathic pulmonary fibrosis with the aid of about twofold. Other environmental and career exposures which includes publicity to metal dirt, wooden dust, coal dirt, silica, stone dust, biologic dusts coming from hay dust or mould spores or other agricultural products, and occupations related to farming/cattle have also been proven to boom the risk for Idiopathic. There is some proof that viral infections can be related to Idiopathic pulmonary fibrosis and other fibrotic lung disease
Interstitial lung disorder may be because of exposure to unsafe chemicals, positive medicines and scientific treatments. In most cases, the reasons are unknown. Lung damage from many ILDs is irreversible and progressive, that means it receives worse over time. In a few cases, it can be slowed by sure medications. Occasionally, people with interstitial lung disease will be recommended for lung transplants. Prolonged Interstitial lung sickness may bring about pulmonary fibrosis; however this isn't usually the case. Idiopathic pulmonary fibrosis is interstitial lung disorder for which no obvious cause may be recognized and is related to normal findings each radiographic and pathologic.
Session 9: Lung Transplantation
Lung harm can regularly be dealt with medicinal drug or with unique breathing devices. But when these measures no longer lung function turns into existence-threatening, physician might suggest a single-lung transplant or a double-lung transplant. Some human beings with coronary artery ailment may want a procedure to restore blood flow to a blocked or narrowed artery in the heart, similarly to a lung transplant. In a few cases, human beings with severe heart and lung situations may want a combined heart-lung transplant
Session 10: Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a situation wherein breathing stops involuntarily for quick durations of time at some point of sleep. Normally, air flows smoothly from the mouth and nose into the lungs in any respect times. In Obstructive sleep apnea , the normal flow of air is time and again stopped all through the night. The waft of air stops because airway space within the region of the throat is too narrow. Snoring is characteristic of Obstructive sleep apnea.
Session 11: Occupational Lung Diseases
Asbestosis: Over time, this ends in lung scarring and stiff lung tissue. It’s frequently linked with creation work.
Coal dirt: This is due to inhaling coal dirt. It reasons lung irritation and scarring. This can motive long-lasting lung harm and shortness of breath.
Silicosis: This is a dust observed within the air of mines, foundries, and blasting operations. It can also increase the chance for different lung sicknesses.
Byssinosis: This is due to inhaling dust from hemp, flax, and cotton processing. It is also called Brown Lung Disease.
Treatments for lung and breathing disorders will depend on the severity and sometimes root cause of the disease. Our team of specialists will work closely with you to develop an individualized treatment plan, diagnosis and therapies.
Each shape of Pulmonary hypertension is different, so it is important for newly-diagnosed sufferers to discover a Pulmonary hypertension expert who can accurately locate what is causing their Pulmonary hypertension and increase a remedy plan that is right for that specific kind of Pulmonary hypertension as quickly as possible. Every individual with pulmonary hypertension is different, and new studies are being conducted every day with the capability to improve the outlook for people dwelling with this disease. Once in the care of a pulmonary hypertension treating health care group and on appropriate therapy, humans with pulmonary hypertension can stay many years.
Pulmonary rehabilitation is typically precise to the character patient, with the objective of meeting the wishes of the affected person. It is a broad program and may benefit sufferers with lung diseases such as chronic obstructive pulmonary sickness (COPD), sarcoidosis, idiopathic pulmonary fibrosis (IPF) and cystic fibrosis, among others. Although the technique is targeted on the rehabilitation of the affected person him/herself, the family is also involved. The system generally does now not begin until a scientific examination of the affected person has been accomplished through an authorized physician.
It was historically known as "consumption" due to the burden loss. Active contamination happens more often in people with HIV/AIDS and in those who smoke.
Diagnosis of energetic Tuberculosis is primarily based on chest X-rays, in addition to microscopic exam and tradition of frame fluids. Diagnosis of latent Tuberculosis is predicated on the tuberculin skin test (TST) or blood tests. Prevention of Tuberculosis includes screening the ones at high danger, early detection and treatment of cases, and vaccination with the bacillus Calmette-Guérin (BCG) vaccine. Treatment requires using multiple antibiotics over a long period of time. Antibiotic resistance is a growing problem with increasing costs of multiple drug-resistant tuberculosis (MDR-TB) and drastically drug-resistant tuberculosis (XDR-TB).
The respiratory care devices market is expected to reach USD 29.9 billion by 2025 from USD 16.0 billion in 2019, at a CAGR of -12.5% during the forecast period of 2020 to 2025. Due to the outbreak of corona virus globally, there is a sudden rise in the demand for respiratory care devices. Thus, the respiratory care devices market witnessed a CAGR of 261.1% between 2019 and 2020. In 2020, respiratory care devices market reached to USD 58.1 billion. The growth of this market is mainly attributed to the high prevalence of respiratory diseases, rising aging population across the globe, high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. However, a lack of awareness—leading to a large underdiagnosed and undertreated population—and the harmful effects of certain respiratory care devices on neonates have hampered market growth to an extent.
In this report, the respiratory care devices market is segmented on the basis of product, indication, end user, and region.
The COVID-19 outbreak in Wuhan, China, led to the rapid establishment of several hospitals for treating the increasing number of patients. This has been mirrored in other countries as well—Italy and the US also built large hospitals within days to accommodate a growing patient population. In New York, US, the army converted the Javits convention center into a 2,900-bed hospital within four days. Critical care devices are being manufactured in increased quantities to meet growing demand. The state of affairs resulting from the pandemic has resulted in alliances between healthcare and non-healthcare industries to manufacture respiratory care devices.
Respiratory Care Devices Market Dynamics
Drivers: Outbreak of infectious diseases affecting the respiratory system
Infectious respiratory diseases directly drive demand for respiratory care. COVID-19 is the most recent and significant of these diseases; the pandemic has resulted in a surge in demand for personal protection equipment and ventilators, among others. The demand for ventilators has also grown due to the COVID-19 outbreak, resulting in governmental and industrial support for driving the pace of manufacturing. This is indicative of the emphasis on respiratory care in the background of an outbreak; the market is expected to show a healthy growth rate, as a result.
Restrains: Unfavorable reimbursement scenario
Many patients rely on reimbursements to receive treatment. The diagnostic industry as a whole and respiratory care diagnostics, in particular, is presently facing the challenge of lack of reimbursements for various diagnostic tests. Reimbursement policies are dispersed in Europe and are available only for PAP devices and oral appliances in select countries (devices that are not covered by insurance have a low market share in the region). Also, the majority of countries in the Asian and Row regions have negligible reimbursement coverage for respiratory care devices.
Opportunities: Growing demand for home care therapeutic devices
The rapid growth in the global geriatric population, rising incidence of chronic diseases (including COPD and asthma), and the cost advantages of home care devices and services (compared to hospital visits) are the key factors driving the growth of the home healthcare market. The high growth potential in emerging markets, healthcare decentralization, and the evolution of miniaturized devices are some of the major factors that are expected to provide significant growth opportunities to players operating in the respiratory home healthcare market. Owing to the rising healthcare costs, a large number of patients suffering from chronic respiratory diseases prefer to undergo treatments in home care settings. This trend is expected to increase the demand for products such as nebulizers, ventilators, and CPAP devices, as they are used by patients to treat, diagnose, and monitor a variety of respiratory diseases in home care settings.
Challenges: Low awareness and large underdiagnosed and undertreated population
In spite of the high prevalence of major respiratory diseases such as asthma and COPD remain highly underdiagnosed and undertreated. This is particularly evident in developing economies due to the low awareness about these diseases and the unavailability of adequate resources to diagnose these diseases. According to the WHO, more than 90% of COPD deaths and 80% of asthma deaths occur in low- and middle-income countries. COPD develops slowly, and it is usually diagnosed in people aged over 40 years, which makes it difficult to control in the later stages of life. It is estimated that around 70% of COPD patients are underdiagnosed owing to the lack of awareness about the disease. Similar to COPD, asthma is also a highly underdiagnosed and undertreated disease (in around 50% asthmatics)
The inhalers segment is estimated to grow at the highest CAGR in the respiratory care devices market, by type, in 2019
Based upon product, the respiratory care devices market is segmented into therapeutic devices, monitoring devices, diagnostic devices, and consumables & accessories. In 2019, the therapeutic devices segment accounted for the largest share of the respiratory care devices market. The different types of therapeutic devices covered in this report are humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, reusable resuscitators, ventilators, inhalers, masks, nitric oxide delivery units, and oxygen hoods Inhalers segment is anticipated to witness highest CAGR amongst therapeutic devices. Inhalers are widely used in the treatment of major respiratory ailments. They are categorized as metered-dose inhalers (MDIs) and dry-powder inhalers (DPIs). The high incidence of asthma is a key factor driving the growth of the global inhalers market in the forecast period.
The COPD segment will continue to dominate the respiratory care devices indication market during the forecast period
Based on indication, COPD held the largest share of the respiratory care devices market in 2019. This was followed by sleep apnea, asthma, and infectious diseases. The large share of COPD segment can be attributed to the increasing prevalence of smoking and environmental factors. This segment is also expected to show the highest growth in the market, followed by asthma. Moreover, the recent outbreak of COVID-19 will also have an impact on COPD patients. While they are not at a higher risk of contracting the disease, it can have severe effects on such patients. Hence, the high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period.
Hospitals are the largest end users of respiratory care devices
Based on end user, the respiratory care devices market is segmented into broadly categorized into three major end-user segments—hospitals, home care settings, and ambulatory care centers. In 2019, hospitals accounted for the largest market share. Growing public-private partnerships to improve access to healthcare services along with rapid developments in healthcare infrastructure and improving access to healthcare services are expected to be the key factors driving the growth of the respiratory care devices market for hospitals in emerging economies in the coming years.
Asia Pacific market to witness the highest growth during the forecast period
The respiratory market is divided into five regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. These regions are further analyzed at the country levels. North America held the largest share of the respiratory care devices market in 2019, followed by Europe and the Asia Pacific. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, due to due to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, rising per capita income, growing middle-class population, and growing prevalence of tobacco smoking in this region. Also, APAC is becoming a medical tourism hub and is considered as one of the fastest-growing markets for medical procedures and devices. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical tourists to APAC countries, particularly India and China.
Key Market Players:
The respiratory care devices market is dominated by a few globally established players such as Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US). The study categorizes the respiratory care devices market based on type, indication, end user, component at the regional and global level.
In April 2020, Philips launched the PHILIPS RESPIRONICS E30 VENTILATOR. This will enable company to help healthcare professionals by providing superior quality ventilators
In January 2020, Masimo Corporation acquired Connected Care Business from NantHealth (US). This acquisition will support Masimo to assist hospitals in providing constant care through connectivity, automation, and innovative noninvasive monitoring technologies.
In May 2020, Philips did partnership with Masimo. This partnership was aimed at integrating Masimo’s measurement technologies into select intellivue MX-Series multi-parameter monitors to help clinicians examine ventilation status and cerebral oximetry.
In March 2019, ResMed acquired HB Healthcare Safety, a provider of home-based medical equipment for sleep and respiratory care devices.
Respiratory device consists of clinical equipment that assists sufferers with breathing in a extreme medical situation. In addition, the devices deliver remedy to treat numerous breathing sicknesses. Moreover, respiration devices are used for prognosis of breathing problems.
Furthermore, respiratory gadgets facilitate in treatment and tracking of respiration issues. The devices are mostly used for the remedy of different respiration disorders like: obstructive conditions, neuromuscular issues, restrictive conditions, vascular illnesses and other illnesses like pneumonia, tuberculosis, asbestosis etc. Major breathing care devices include CPAP machines, transportable emergency oxygen systems, oximetry meters, nebulizers etc.
Patients with respiratory sickness are handled with one of a kind clinical gadget like: air cleaner, CPAP machines, BiPAP machines, transportable emergency oxygen systems, etc. These, device facilitate the medical experts to efficaciously and efficaciously deal with patients with intense breathing illnesses.
The international breathing gadget market has expanded progressively over time and the marketplace is further expected to propel at a regular pace at some point of the forecasted years 2020 to 2024. The market would propel as a result of one of a kind boom drivers like surging ageing population, rising healthcare expenditure, growing continual sicknesses, escalating cigarette consumption, rise in carbon emission, escalating obese populace and surging diabetic population.However, the marketplace faces a few demanding situations which might be obstructing the growth of the market. Some of the essential challenges faced with the aid of the industry are: fast technological advancement, stringent product approval and tracking regulatory, existence of neighborhood manufacturers, loss of raw fabric availability and outcomes of breathing devices on infants.
Meetings International is announcing Young Scientist Awards through 2nd International Conference on Respiratory Disease and Care (Respiratory Care 2021) which is scheduled Berlin, Germany Ber during April 19-20, 2020. This Respiratory Care Conference focuses on “OPTIMIZING RESEARCH STRATEGIES FOR LUNG DISORDER TREATMENTS”.
Respiratory Care 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of environmental science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.
Respiratory Care 2021 focuses mainly on Respiratory Distress, Pathogenesis of COPD, Drugs & Diagnostic Evolution of COPD, Asthma Immunology & Medication, Immunotherapy & Transplantation, Chronic Respiratory Diseases, Acute Respiratory Distress Syndrome, Targeted Therapy for Lungs Cancer. Respiratory Care conference operating committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.
Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.
Official announcement of the recipients will occur after the completion of Recycling Conference.
International Conference on Respiratory Disease & Care provides liability to all the global emirates to grow your business globally and sell your Research Materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, Instruments. Breathe life into your products and make moment brand mindfulness with a pennant advertisement arrangement. Make your pennant intuitive to guide individuals to where you need them to go.
Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world. 3+ Million Website Visitors, 40000+ Conference Website Visitors and 1000+ Sessions which confirm the outstanding pool of new users and visitors creating a platform to build your market place globally. Meetings International helps you to connect with global clients anywhere at any time via our unrivalled, worldwide professionals reach. Start promoting your brand today, basically browse our immense scope of custom fitted, multi-channel publicizing and sponsorship alternatives across print and computerized stages and select the geology of your intended interest group.
We maintain high quality and ethical standards in event industry, which makes us unique and better than the rest. Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
For further queries, connect our conference manager at firstname.lastname@example.org; email@example.com
You can also connect us via WhatsApp: +65 3158 1626 / + 44 7482 874377
Learning In a New Space
New Tips & Tactics